Epipodophyllotoxins: new laboratory and clinical findings.
Muggia
F M
FM
University of Southern California, Los Angeles.
Gill
I
I
D004334:Drug Administration Schedule; D004351:Drug Resistance; D006801:Humans; D011034:Podophyllotoxin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D011034:Podophyllotoxin